Trupanion, Inc. (NASDAQ:TRUP) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $45.50.

A number of brokerages recently issued reports on TRUP. Stifel Nicolaus dropped their target price on shares of Trupanion from $38.00 to $35.00 and set a “hold” rating on the stock in a research report on Friday. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Cantor Fitzgerald dropped their price objective on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a report on Wednesday, January 14th. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 6th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a research report on Monday, December 29th.

Insider Transactions at Trupanion

In related news, CEO Margaret Tooth sold 9,605 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $37.88, for a total value of $363,837.40. Following the completion of the transaction, the chief executive officer directly owned 150,294 shares in the company, valued at approximately $5,693,136.72. This represents a 6.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 6,202 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $35.45, for a total value of $219,860.90. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 32,853 shares of company stock valued at $1,181,863. 5.42% of the stock is owned by corporate insiders.

Institutional Trading of Trupanion

Several institutional investors have recently made changes to their positions in TRUP. Federated Hermes Inc. acquired a new position in Trupanion in the third quarter worth about $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Trupanion in the 3rd quarter valued at approximately $39,000. Nisa Investment Advisors LLC raised its holdings in shares of Trupanion by 44.1% in the 2nd quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock worth $54,000 after buying an additional 300 shares in the last quarter. Kelleher Financial Advisors acquired a new position in shares of Trupanion in the 3rd quarter worth approximately $74,000. Finally, PNC Financial Services Group Inc. lifted its position in shares of Trupanion by 21.7% during the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after buying an additional 478 shares during the period.

Trupanion Price Performance

NASDAQ TRUP opened at $27.96 on Monday. The stock has a 50-day simple moving average of $34.86 and a 200 day simple moving average of $39.99. Trupanion has a twelve month low of $27.30 and a twelve month high of $57.88. The stock has a market capitalization of $1.21 billion, a PE ratio of 62.13 and a beta of 1.58. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.71 and a current ratio of 1.69.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The business had revenue of $376.85 million during the quarter, compared to the consensus estimate of $375.89 million. During the same period in the prior year, the firm earned $0.04 earnings per share. The business’s quarterly revenue was up 11.7% on a year-over-year basis. Research analysts anticipate that Trupanion will post 0.13 EPS for the current year.

Trupanion News Summary

Here are the key news stories impacting Trupanion this week:

• Positive Sentiment: Management reiterated operational momentum: a 2026 target of ~14% subscription revenue growth, plus company commentary on record retention and margin gains that support longer‑term revenue visibility and profitability expansion. Article Title
• Positive Sentiment: Top‑line growth remained solid: Q4 revenue of $376.85M was up ~11.7% year‑over‑year and essentially in line with estimates; management also highlighted cumulative discretionary profit generation (>$500M since 2021), supporting free‑cash‑flow optionality. Article Title
• Neutral Sentiment: Guidance largely in line with consensus: FY‑2026 revenue was guided to roughly $1.6B and Q1 revenue to $376–382M (close to street estimates), suggesting no material upside surprise in near‑term top‑line trajectory. Article Title
• Negative Sentiment: Earnings missed marginally: Q4 EPS came in at $0.13 versus the $0.14 consensus (a $0.01 miss), which, combined with a thin net margin (~1.1%), disappointed some income‑oriented and growth investors. Article Title
• Negative Sentiment: Market reaction and positioning: the stock had already experienced a steep slide into the print; investors reacted to the EPS miss and nondisruptive guidance by selling, producing elevated volume and driving the share price lower. Article Title Article Title

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.